DUSA Pharmaceuticals' Actinic Keratosis PDT Treatment Is Tip Of Pipeline
This article was originally published in The Gray Sheet
Executive Summary
DUSA Pharmaceuticals plans to submit a premarket approval application supplement within the next two months for the commercial version of the firm's BLU-U light source used in conjunction with the Levulan Kerastick actinic keratoses therapy.